Meta Platforms Inc (NASDAQ: META) Is Getting Increasingly Hard To Ignore

Currently, there are 2.19B common shares owned by the public and among those 2.18B shares have been available to trade.

The company’s stock has a 5-day price change of 3.68% and 24.82% over the past three months. META shares are trading 22.03% year to date (YTD), with the 12-month market performance up to 57.13% higher. It has a 12-month low price of $414.50 and touched a high of $718.90 over the same period. META has an average intraday trading volume of 13.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.06%, 14.41%, and 30.86% respectively.

Institutional ownership of Meta Platforms Inc (NASDAQ: META) shares accounts for 67.08% of the company’s 2.19B shares outstanding.

It has a market capitalization of $1810.52B and a beta (3y monthly) value of 1.23. The stock’s trailing 12-month PE ratio is 29.87, while the earnings-per-share (ttm) stands at $23.92. The company has a PEG of 2.60 and a Quick Ratio of 2.98 with the debt-to-equity ratio at 0.27. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.67% over the week and 2.98% over the month.

Earnings per share for the fiscal year are expected to increase by 5.64%, and 13.72% over the next financial year. EPS should shrink at an annualized rate of 11.47% over the next five years, compared to 29.99% over the past 5-year period.

Looking at the support for the META, a number of firms have released research notes about the stock. The Benchmark Company stated their Buy rating for the stock in a research note on January 30, 2025, with the firm’s price target at $820. BofA Securities coverage for the Meta Platforms Inc (META) stock in a research note released on January 23, 2025 offered a Buy rating with a price target of $710. Cantor Fitzgerald was of a view on January 22, 2025 that the stock is Overweight, while Jefferies gave the stock Buy rating on January 06, 2025, issuing a price target of $675- $715. Wolfe Research on their part issued Outperform rating on January 03, 2025.

Most Popular

Related Posts